Blog

The Toffler Scholar Program supports medical investigators engaged in early-stage, innovative medical research. The Karen Toffler Charitable Trust is pleased to announce the 2025 Toffler Scholar Awards. This year, KTCT is providing $708,000 in funding to 13 researchers whose early-stage projects hold extraordinary potential to drive meaningful scientific breakthroughs. Chosen from an applicant pool spanning…

The global research and development (R&D) ecosystem is estimated to grow to $1.25T by 2025. Fueled by investments from across the public and private sectors, this rapidly changing arena is becoming increasingly and incredibly diverse. What was once primarily a government-fueled engine of innovation has expanded to encompass businesses, nonprofits, foundation entities, and more. Likewise,…

Since our official launch in 2019, The Karen Toffler Charitable Trust (KTCT) has been providing essential funding and forging meaningful connections to support, promote, and advance the work of researchers who are exploring medical solutions at the furthest edges of science.

The Karen Toffler Charitable Trust (KTCT) is supporting cutting-edge scientists like Dr. LaVoie to explore the uncharted territory of high-risk research. With their funding, Dr. LaVoie has uncovered an exciting new avenue of research that could revolutionize the way we approach Lewy Body Dementia. When Dr. LaVoie was awarded a Grant from the Karen Toffler…

The global research and development (R&D) ecosystem is changing rapidly and dramatically. An arena once dominated, fueled, and funded by U.S. federal government organizations like the National Science Foundation, NIH, NASA, Office of Naval Research, and the Defense Advanced Research Projects Agency (DARPA) is now being driven — and bankrolled — by investors from industry,…

University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder. The findings were published…